COVID-19–related Ocular Hypertension Secondary to Anterior Uveitis as Part of a Multisystemic Inflammatory Syndrome

Alonso, Ruiz Simonato; Alonso, Fabio O M; Fernandes, Bruno F.; Ecard, Virginia O; Ventura, Marcelo Palis

doi:10.1097/ijg.0000000000001835

Cited by 19 publications

(14 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 114 COVID‐19 may be associated with ocular complications, including anterior uveitis, which is usually leading to intraocular pressure. 115 Orbital myositis in the absence of typical systemic COVID‐19 manifestations was reported in a 10‐year‐old boy; alarming the possible association of this event with coronavirus. 116 According to an investigation performed in 104 confirmed COVID‐19 who required mechanical ventilation, 21.9% had eye lesions with a similar rate of intraocular lesions in patients in both the ward or intensive care unit.…”

Section: Methodsmentioning

confidence: 97%

The overall impact of COVID‐19 on healthcare during the pandemic: A multidisciplinary point of view

Sabetkish

Rahmani

2021

Health Science Reports

View full text Add to dashboard Cite

Background and Aims The Coronavirus disease 2019 (COVID‐19) pandemic globally changed the priorities of medical and surgical procedures. It has caused many healthcare systems to stop performing their routine screenings. Altering medical clinics to COVID‐19 referral centers, lockdowns, and the public fear to refer to medical centers caused a significant reduction in the referral rate; especially in the elderly. This short review article highlights the transform in clinical practice during the post‐COVID era and the need for future medical revolutions. Methods A comprehensive literature search was separately performed by both authors. The articles published between 2019 and August 2021 were included in this study and selected according to a quality appraisal method. Results We have summarized the possible corresponding changes in the diagnosis and treatment of all fields of medical care including internal medicine, surgical, and minor subcategories after the COVID‐19 pandemic. We have also discussed the potential impacts of the pandemic on all these different categories and subcategories of medicine, including the outpatient setting and clinical work. We do believe that the lack of routine check‐ups has led to an increase in the stage of disease in patients with a previously diagnosed problem. On the other hand, the dramatic change in the lifestyle of the population including restricted mobility and increased consumption of unhealthy food has caused metabolic syndrome and other new diseases that have not been diagnosed and properly managed. Conclusion Our findings revealed the urgent need for public health awareness. It indicated the need to carry out both psychological and screening approaches in the post‐COVID era to not miss patients with a chronic disease and new cases who were undiagnosed during the COVID pandemic.

show abstract

Section: Methodsmentioning

confidence: 97%

The overall impact of COVID‐19 on healthcare during the pandemic: A multidisciplinary point of view

Sabetkish

Rahmani

2021

Health Science Reports

View full text Add to dashboard Cite

show abstract

“…Optic neuritis, disk edema, vascular tortuosity, acute macular neuroretinopathy (AMN), vasculitis retinal occlusion (RVO), retinal artery occlusions, intraretinal hemorrhages, cotton wool spots, uveitis, and endogenous endophthalmitis have all been reported in COVID-19 patients. 53 – 58…”

Section: Adults’ Ocular Manifestationsmentioning

confidence: 99%

Ocular manifestations of COVID-19

Al-Namaeh¹

2022

Ophthalmol Eye Dis

View full text Add to dashboard Cite

COVID-19 is a disease caused by a SARS-CoV-2 viral infection, a disease that was first detected in December 2019 in Wuhan, Hubei Province, China. COVID-19, formerly known as 2019 Novel Coronavirus (2019-nCoV) respiratory disease, was officially named COVID-19 by the World Health Organization (WHO) in February 2020. By 25 May 2021, there were 33,579,116 confirmed cases with 599,109 COVID-19 deaths worldwide. The purpose of this review article is to provide an update on what is currently known about COVID-19 ocular symptoms in adults, the elderly, and children in the literature. Finally, this article will review the eye protection precautions that should be implemented in our clinics. To assess the current literature, PubMed was searched from December 2019 to 25 May 2021. Randomized trials, observational studies, case series or case reports, letters of research, and letters to editors were selected for confirmed cases of COVID-19. According to current scientific literature since the outbreak in December 2019, 205 articles have been published. Conjunctivitis, conjunctival hyperemia, and chemosis have been reported in adults with COVID-19. There have been few studies on children and elderly patients, and further research in these age groups is needed. Finally, wearing eye protection when seeing patients on a daily basis during the pandemic is essential.

show abstract

“…We found higher IOP values after COVID-19 in both groups. As COVID-19 is a systemic in ammatory syndrome, damage to trabecular meshwork function or anterior uveitis may lead to an increase in the IOP [4] , [18]. In addition, systemic corticosteroid (CS) treatment, regardless of route, used to manage COVID-19 or topical CS for uveitis may raise IOP.…”

Section: Pappazoglu Et Al Reported No Relevant Changes In Iop Values ...mentioning

confidence: 99%

“…Ocular complications associated with COVID-19 are mild and self-limiting [4]. Subtle retinal changes like hyperre ective lesions at the level of the ganglion cell-inner plexiform layers (GCIPL) on optical coherence tomography (OCT), cotton-wool spots, and microhemorrhages have also been reported [1,2].. Glaucoma is de ned as structural damage to the optic nerve (ON) which is associated with functional damage to be indicated by visual dysfunction.…”

Section: Introductionmentioning

confidence: 99%

The Course of Glaucoma in Recovered COVID-19 Patients

Sevimli

Saygın

2022

Preprint

View full text Add to dashboard Cite

Purpose To observe the course of glaucoma progression after coronavirus disease 2019 (COVID-19) treatment of patients with a previous history of glaucoma. Design Multicentric observational case-control study Materials and Methods This observational case-control study included total 74 patients with COVID-19 infection who were diagnosed with glaucoma previously. The study focused on the left eye of 37 patients each were treated as inpatient or outpatient. Age, gender, existence of systemic and ocular diseases, symptoms, laboratory results, drugs used for COVID-19 and glaucoma, length of hospital stay, intraocular pressure (IOP), and central corneal thickness (CCT) values were recorded. Peripapillary retinal nerve fiber layer thickness (ppRNFLT), ganglion cell–inner plexiform layer complex thickness (GCIPLT) and vertical cup-disc (C-D) ratio results were compared before (pre-COVID-19) and after (post-COVID-19) COVID-19 treatment in both groups. Results A significant increase was observed in IOP values in both inpatient and outpatient groups (p = 0,02, p < 0,01 respectively) after COVID-19 infection. However, mean difference (MD) was higher in inpatient group for IOP levels (-1,76). Inpatient and outpatient groups showed statistically significant decrease in GCIPLT values post-COVID-19 (p < 0,01 and p = 0,02, respectively). In addition, MD value was higher in inpatient group (2,72). A significant decrease was observed in ppRNFLT values in inpatient group after COVID-19 infection (p = 0,03). In both groups, the mean C-D ratio was higher post-COVID-19. Conclusion PpRNFLT and GCIPLT values were reduced and IOP and C-D ratio values were increased in glaucoma patients after COVID-19 infection. Infection progression observed to be worse in inpatient group.

show abstract

COVID-19–related Ocular Hypertension Secondary to Anterior Uveitis as Part of a Multisystemic Inflammatory Syndrome

Cited by 19 publications

References 12 publications

The overall impact of COVID‐19 on healthcare during the pandemic: A multidisciplinary point of view

The overall impact of COVID‐19 on healthcare during the pandemic: A multidisciplinary point of view

Ocular manifestations of COVID-19

The Course of Glaucoma in Recovered COVID-19 Patients

Contact Info

Product

Resources

About